Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal...

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Thapsigargin, an endomembrane Ca2+-ATPase inhibitor, was previously shown to induce intracellular platelet-activating factor (PAF) production.
• Nuclear factor (NF)-kappaB is a key transcription factor involved in inflammatory responses.

Purpose of the Study:

• To investigate the role of intracellular PAF in NF-kappaB activation in thapsigargin-stimulated rat peritoneal macrophages.
• To determine if intracellular PAF mediates NF-kappaB activation induced by thapsigargin or lipopolysaccharide (LPS).

Main Methods:

• Rat peritoneal macrophages were stimulated with thapsigargin.
• Levels of inhibitory protein of NF-kappaB-alpha (IkappaB-alpha) and nuclear translocation of NF-kappaB were measured.
• The effects of PAF synthesis inhibitors and PAF antagonists on NF-kappaB activation were assessed.
• Exogenously added PAF was tested for its effect on IkappaB-alpha degradation.

Main Results:

• Thapsigargin stimulation led to decreased IkappaB-alpha levels and increased NF-kappaB nuclear translocation.
• PAF synthesis inhibitors and PAF antagonists blocked thapsigargin-induced NF-kappaB activation.
• These drugs also suppressed LPS-induced NF-kappaB activation.
• Exogenous PAF did not induce IkappaB-alpha degradation in cultured macrophages.

Conclusions:

• Intracellular PAF, produced upon stimulation with thapsigargin or LPS, plays a role in activating the NF-kappaB pathway in macrophages.
• The findings suggest an intracellular signaling role for PAF in NF-kappaB activation, distinct from exogenous PAF effects.